Non-covalent modification of thrombolytic agent nattokinase: simultaneous improvement of fibrinolysis activity and enzymatic stability

C Chen, H Duan, C Gao, M Liu, Y Wei, X Zhang, Z Liu - RSC Advances, 2014 - pubs.rsc.org
Cardiovascular disease (CVD) has become the leading cause of death globally. Nattokinase
(NK), as a novel thrombolytic agent, has gained more and more attention. However, NK is …

[HTML][HTML] Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex

R Feng, J Li, J Chen, L Duan, XR Liu, D Di… - asian journal of …, 2018 - Elsevier
Nattokinase (NK), which has been identified as a potent fibrinolytic protease, has
remarkable potential in treatment of thrombolysis, and even has the ability to ameliorate …

Effect of Tb (III) on activity and stability of nattokinase

MOU Xiaochao, Y Renjia, W ZHANG, Y Binsheng - Journal of Rare Earths, 2017 - Elsevier
Nattokinase, is an effective fibrinolytic enzyme with the potential for fighting cardiovascular
disease. The aim of study was to investigate the interaction of Tb (III) with nattokinase and …

Downstream processing, formulation development and antithrombotic evaluation of microbial nattokinase

R Kapoor, H Harde, S Jain, AK Panda… - Journal of Biomedical …, 2015 - ingentaconnect.com
The present research work describes the downstreaming of nattokinase (NK) produced by
Bacillus subtilis under solid state fermentation; and the role of efficient oral formulation of …

[HTML][HTML] Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease

Y Weng, J Yao, S Sparks, KY Wang - International journal of molecular …, 2017 - mdpi.com
Natto, a fermented soybean product, has been consumed as a traditional food in Japan for
thousands of years. Nattokinase (NK), a potent blood-clot dissolving protein used for the …

Improvement of the acid resistance, catalytic efficiency, and thermostability of nattokinase by multisite‐directed mutagenesis

Z Liu, H Zhao, L Han, W Cui, L Zhou… - Biotechnology and …, 2019 - Wiley Online Library
Nattokinase (NK) is a serine protease of the subtilisin family; as a potent fibrinolytic enzyme,
it is potentially useful for thrombosis therapy. For NK to be applied as an oral medicine for …

Improvement of the fibrinolytic activity, acid resistance and thermostability of nattokinase by surface charge engineering

Y Li, X Tang, L Chen, A Ma, W Zhu, W Huang… - International Journal of …, 2023 - Elsevier
Nattokinase is a promising thrombolytic drug due to its powerful fibrinolytic effect and few
side effects. However, the low fibrinolytic activity and stability of nattokinase have limited its …

Nattokinase-heparin exhibits beneficial efficacy and safety—An optimal strategy for CKD patients on hemodialysis

H Wu, H Wang, W Li, C Zhang, Y Liu, F Xu, J Chen… - Glycoconjugate …, 2019 - Springer
Heparin is a widely used anticoagulant in hemodialysis (HD) for patients with chronic kidney
disease (CKD); however, it entails the risk of thrombus formation due to heparin-induced …

In vitro and in silico studies on fibrinolytic activity of nattokinase: A clot buster from Bacillus sp.

V Mohanasrinivasan, A Mohanapriya, S Potdar… - Frontiers in biology, 2017 - Springer
Background Nattokinase (NK) is a serine protease enzyme of the subtilisin family. It exhibits
a strong fibrinolytic activity. The fibrinolytic enzymes from Bacillus sp. have attracted interest …

[HTML][HTML] A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles

Y Kurosawa, S Nirengi, T Homma, K Esaki, M Ohta… - Scientific reports, 2015 - nature.com
Our aim was to determine the quantitative effects of a single-dose of Nattokinase (NK)
administration on coagulation/fibrinolysis parameters comprehensively in healthy male …